NO20053032L - Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon. - Google Patents
Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon.Info
- Publication number
- NO20053032L NO20053032L NO20053032A NO20053032A NO20053032L NO 20053032 L NO20053032 L NO 20053032L NO 20053032 A NO20053032 A NO 20053032A NO 20053032 A NO20053032 A NO 20053032A NO 20053032 L NO20053032 L NO 20053032L
- Authority
- NO
- Norway
- Prior art keywords
- regulation
- disturbance
- treatment
- production
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår anvendelsen av 2, 5-dihydroxybenzensulfonforbindelser for fremstilling av medikamenter for regulering av nitrogenoksid (NO) syntese og/eller regulering av EDHF (Endothelium-Derived-Hyperpolarizing-Factor) i endotelium hos diabetiske pasienter, hvorved medikamentet blir administrert i en daglig dose av 2, 5dihydroxybenzensulfonforbindelsene med formel (I) på < 500 mg.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200202755A ES2208124B1 (es) | 2002-11-29 | 2002-11-29 | Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento. |
PCT/EP2003/013469 WO2004050075A1 (en) | 2002-11-29 | 2003-11-29 | Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20053032L true NO20053032L (no) | 2005-06-20 |
Family
ID=32405966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053032A NO20053032L (no) | 2002-11-29 | 2005-06-20 | Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060135611A1 (no) |
EP (1) | EP1596850A1 (no) |
JP (1) | JP2006509778A (no) |
CN (1) | CN1744891A (no) |
AR (1) | AR042152A1 (no) |
AU (1) | AU2003289914A1 (no) |
BR (1) | BR0316134A (no) |
CA (1) | CA2507750A1 (no) |
ES (1) | ES2208124B1 (no) |
MX (1) | MXPA05005719A (no) |
NO (1) | NO20053032L (no) |
RU (1) | RU2005120634A (no) |
WO (1) | WO2004050075A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006080481A1 (ja) * | 2005-01-31 | 2008-06-19 | 杏林製薬株式会社 | マルチプルユニット型経口徐放性製剤及びその製造方法 |
FR2902096B1 (fr) * | 2006-06-13 | 2011-03-18 | Rhodia Recherches & Tech | Procede de preparation de dihydroxybenzenedisulfonates metalliques |
US9198886B2 (en) * | 2006-08-16 | 2015-12-01 | Pedro Cuevas Sánchez | Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
US20080182513A1 (en) * | 2007-01-29 | 2008-07-31 | Hassan Amer A | High Frequency Communications |
CN102038671B (zh) * | 2010-06-29 | 2012-07-04 | 辽宁思百得医药科技有限公司 | 包含左卡尼汀和羟苯磺酸盐的药物组合物 |
CN114601816B (zh) * | 2021-10-09 | 2022-09-02 | 北京惠之衡生物科技有限公司 | 一种羟苯磺酸钙胶囊组合物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2608045B1 (fr) * | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
FR2656525A1 (fr) * | 1989-12-29 | 1991-07-05 | Delalande Sa | Formes d'administration de medicament a liberation controlee et leur procede de fabrication. |
DE4413350A1 (de) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
DE69735417T2 (de) * | 1996-04-03 | 2006-09-21 | Laboratorios Del Dr. Esteve S.A. | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen |
DE10016356B4 (de) * | 2000-04-03 | 2007-06-21 | Beisel, Günther | Mittel mit verbesserter Retardwirkung und Verfahren zu dessen Herstellung |
-
2002
- 2002-11-29 ES ES200202755A patent/ES2208124B1/es not_active Expired - Fee Related
-
2003
- 2003-11-29 RU RU2005120634/04A patent/RU2005120634A/ru not_active Application Discontinuation
- 2003-11-29 EP EP03782253A patent/EP1596850A1/en not_active Ceased
- 2003-11-29 AU AU2003289914A patent/AU2003289914A1/en not_active Abandoned
- 2003-11-29 CA CA002507750A patent/CA2507750A1/en not_active Abandoned
- 2003-11-29 WO PCT/EP2003/013469 patent/WO2004050075A1/en not_active Application Discontinuation
- 2003-11-29 JP JP2004556233A patent/JP2006509778A/ja active Pending
- 2003-11-29 CN CNA2003801093431A patent/CN1744891A/zh active Pending
- 2003-11-29 BR BR0316134-0A patent/BR0316134A/pt not_active IP Right Cessation
- 2003-11-29 MX MXPA05005719A patent/MXPA05005719A/es not_active Application Discontinuation
- 2003-11-29 US US10/536,782 patent/US20060135611A1/en not_active Abandoned
- 2003-12-01 AR ARP030104411A patent/AR042152A1/es not_active Application Discontinuation
-
2005
- 2005-06-20 NO NO20053032A patent/NO20053032L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2208124B1 (es) | 2005-10-01 |
CA2507750A1 (en) | 2004-06-17 |
RU2005120634A (ru) | 2006-03-27 |
AU2003289914A1 (en) | 2004-06-23 |
BR0316134A (pt) | 2005-10-11 |
MXPA05005719A (es) | 2005-08-16 |
US20060135611A1 (en) | 2006-06-22 |
ES2208124A1 (es) | 2004-06-01 |
EP1596850A1 (en) | 2005-11-23 |
CN1744891A (zh) | 2006-03-08 |
JP2006509778A (ja) | 2006-03-23 |
WO2004050075A1 (en) | 2004-06-17 |
AR042152A1 (es) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402217A2 (hu) | Platinaszármazékot tartalmazó gyógyászati készítmények | |
WO2001039759A3 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
MX9709977A (es) | Compuestos de (acido sulfinico, acido sulfonico, sulfonilamino o sulfinilamino) n-[(aminoiminometil) fenilalquil] azaheterociclilamida sustituidos. | |
HUP0204023A2 (hu) | Pirrolidinacetamidszármazék alkalmazása önmagában vagy kombinációban központi idegrendszeri zavarok kezelésére és ezeket tartalmazó gyógyszerkészítmények | |
EA200400881A1 (ru) | Азаарилпиперазины | |
BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
NO20053032L (no) | Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon. | |
HUP0402422A2 (hu) | Deuterizált szubsztituált pirazolil-benzolszulfonamid-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
NO20005912L (no) | Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser | |
ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
HUP0402304A2 (hu) | Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
NO20061515L (no) | Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn | |
HUP0401798A2 (hu) | Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására | |
LT2006026A (lt) | 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimo pablogėjimui | |
NO20013480L (no) | Legemiddel for torr hud | |
RU2005140516A (ru) | Применение ингибитора тирозинкиназы для лечения диабета | |
HUP0002905A2 (hu) | 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása | |
LT2006025A (lt) | 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimui | |
TW200515912A (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
HUP0200148A2 (hu) | N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére | |
HUP0200129A2 (hu) | N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére | |
CY1115006T1 (el) | Παρατεταμενη απελευθερωση αντιμολυσματικων φαρμακων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |